These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11758660)

  • 1. Impact of clozapine prescription on inpatient resource utilization.
    Sernyak MJ; Rosenheck R; Desai R; Stolar M; Ripper G
    J Nerv Ment Dis; 2001 Nov; 189(11):766-73. PubMed ID: 11758660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of clozapine on completed suicide.
    Sernyak MJ; Desai R; Stolar M; Rosenheck R
    Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of clozapine treatment in therapy-refractory schizophrenia.
    Jonsson D; Wålinder J
    Acta Psychiatr Scand; 1995 Sep; 92(3):199-201. PubMed ID: 7484198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should receive high-cost mental health treatment and for how long?
    Rosenheck R; Massari L; Frisman L
    Schizophr Bull; 1993; 19(4):843-52. PubMed ID: 8303231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical and economic follow-up of patients on clozapine.
    Honigfeld G; Patin J
    Hosp Community Psychiatry; 1990 Aug; 41(8):882-5. PubMed ID: 2401478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Business Case for Expanded Clozapine Utilization.
    Gören JL; Rose AJ; Smith EG; Ney JP
    Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
    Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
    Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine therapy for older veterans.
    Sajatovic M; Ramirez LF; Garver D; Thompson P; Ripper G; Lehmann LS
    Psychiatr Serv; 1998 Mar; 49(3):340-4. PubMed ID: 9525793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of rehospitalisation in schizophrenia.
    Dey S; Menkes DB; Obertova Z; Chaudhuri S; Mellsop G
    Australas Psychiatry; 2016 Aug; 24(4):356-9. PubMed ID: 26906441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY; Cola P; Way L; Thompson PA; Bastani B; Davies MA; Snitz B
    Am J Psychiatry; 1993 Nov; 150(11):1630-8. PubMed ID: 8105705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital days in clozapine-treated patients.
    Dickson RA; Dalby JT; Williams R; Warden SJ
    Can J Psychiatry; 1998 Nov; 43(9):945-8. PubMed ID: 9825168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program.
    Wu MK; Wang CK; Bai YM; Huang CY; Lee SD
    Psychiatr Serv; 2007 Apr; 58(4):544-50. PubMed ID: 17412858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability status and length of stay at a VA medical center.
    Pary R; Turns DM; Stephenson JJ; Tobias C; Lippmann S
    Hosp Community Psychiatry; 1992 Aug; 43(8):844-5. PubMed ID: 1427691
    [No Abstract]   [Full Text] [Related]  

  • 19. Inpatient hospital utilization among veterans with traumatic spinal cord injury.
    Samsa GP; Landsman PB; Hamilton B
    Arch Phys Med Rehabil; 1996 Oct; 77(10):1037-43. PubMed ID: 8857883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.
    Hayhurst KP; Brown P; Lewis SW
    J Psychopharmacol; 2002 Jun; 16(2):169-75. PubMed ID: 12095076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.